Agency Information Collection Activities: Submission for OMB Review; Comment Request, 52917 [2021-20608]

Download as PDF 52917 Federal Register / Vol. 86, No. 182 / Thursday, September 23, 2021 / Notices Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Trinh T. Tran, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 827–5843, trinh.tran@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Animal Genomics Program (U01—Clinical Trial Not Allowed). Date: November 5, 2021. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ipolia R. Ramadan, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 827–4471, ramadanir@mail.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Assessing the Effects of Cannabinoids on HIV-Associated Persistent Inflammation (R01 Clinical Trial Optional). Date: November 19, 2021. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 594–9460, Soyoun.cho@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: September 17, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–20581 Filed 9–22–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–0361. Proposed Project: Division of State Programs—Management Reporting Tool (DSP–MRT) (OMB No. 0930–0354)—Revision The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) aims to monitor several substance use prevention programs through the DSP–MRT, which reports data using the Strategic Prevention Framework (SPF). Programs monitored through the DSP–MRT include: SPF-Partnerships for Success (PFS), SPF- Prescription Drugs (Rx), Prescription Drug Overdose (PDO), and First Responder-Comprehensive Addiction and Recovery Act (FR– CARA). SAMHSA also proposed adding a new program: Sober Truth on Preventing Underage Drinking Act Grants (STOP Act). This request for data collection includes minor revisions from a previously approved OMB instrument. Monitoring data using the SPF model will allow SAMHSA’s project officers to systematically collect data to monitor their grant program. In addition to assessing activities related to the SPF steps, the performance monitoring instruments covered in this statement collect data to assess the following grantee required specific performance measures: • Number of training and technical assistance activities per funded community provided by the grantee to support communities • Reach of training and technical assistance activities (numbers served) provided by the grantee • Percentage of subrecipient communities that submit data to the grantee data system • Number of subrecipient communities that improved on one or more targeted National Outcome Measures • Number of grantees who integrate Prescription Drug Monitoring Program data into their program needs assessment • Number of naloxone toolkits distributed Revisions to this package include the following: • Inclusion of six performance targets • Removal of outdated references • Adjustments to the language in the Disparities Impact Section to refine response ANNUALIZED DATA COLLECTION BURDEN Number of respondents lotter on DSK11XQN23PROD with NOTICES1 Instrument Responses per respondent Total number of responses Total burden hours Hours per response Average hourly wage Total respondent cost a DSP–MRT ..................................................... PFS Supplemental ........................................ PDO/FR CARA Supplemental ...................... SPF Rx Supplemental ................................... STOP Act Supplemental ............................... 521 253 109 26 133 4 1 2 4 1 2,084 253 218 104 133 3 1 1 1 1 6,252 253 218 104 133 $44.19 44.19 44.19 44.19 44.19 $276,276 11,180 9,633 4,596 5,877 FY2021–FY2024 Total ........................... 521 ........................ ........................ ........................ 6,960 ........................ 307,562 Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting VerDate Sep<11>2014 17:19 Sep 22, 2021 Jkt 253001 ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Carlos Graham, Social Science Analyst. [FR Doc. 2021–20608 Filed 9–22–21; 8:45 am] BILLING CODE 4162–20–P PO 00000 Frm 00046 Fmt 4703 Sfmt 9990 E:\FR\FM\23SEN1.SGM 23SEN1

Agencies

[Federal Register Volume 86, Number 182 (Thursday, September 23, 2021)]
[Notices]
[Page 52917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20608]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under OMB review, in compliance with the Paperwork 
Reduction Act (44 U.S.C. chapter 35). To request a copy of these 
documents, call the SAMHSA Reports Clearance Officer on (240) 276-0361.

Proposed Project: Division of State Programs--Management Reporting Tool 
(DSP-MRT)

(OMB No. 0930-0354)--Revision

    The Substance Abuse and Mental Health Services Administration's 
(SAMHSA) Center for Substance Abuse Prevention (CSAP) aims to monitor 
several substance use prevention programs through the DSP-MRT, which 
reports data using the Strategic Prevention Framework (SPF). Programs 
monitored through the DSP-MRT include: SPF-Partnerships for Success 
(PFS), SPF- Prescription Drugs (Rx), Prescription Drug Overdose (PDO), 
and First Responder-Comprehensive Addiction and Recovery Act (FR-CARA). 
SAMHSA also proposed adding a new program: Sober Truth on Preventing 
Underage Drinking Act Grants (STOP Act). This request for data 
collection includes minor revisions from a previously approved OMB 
instrument.
    Monitoring data using the SPF model will allow SAMHSA's project 
officers to systematically collect data to monitor their grant program. 
In addition to assessing activities related to the SPF steps, the 
performance monitoring instruments covered in this statement collect 
data to assess the following grantee required specific performance 
measures:

 Number of training and technical assistance activities per 
funded community provided by the grantee to support communities
 Reach of training and technical assistance activities (numbers 
served) provided by the grantee
 Percentage of subrecipient communities that submit data to the 
grantee data system
 Number of subrecipient communities that improved on one or 
more targeted National Outcome Measures
 Number of grantees who integrate Prescription Drug Monitoring 
Program data into their program needs assessment
 Number of naloxone toolkits distributed

    Revisions to this package include the following:

 Inclusion of six performance targets
 Removal of outdated references
 Adjustments to the language in the Disparities Impact Section 
to refine response

                                                            Annualized Data Collection Burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                               Total
               Instrument                    Number of     Responses per   Total number      Hours per     Total  burden      Average       respondent
                                            respondents     respondent     of responses      response          hours       hourly  wage      cost \a\
--------------------------------------------------------------------------------------------------------------------------------------------------------
DSP-MRT.................................             521               4           2,084               3           6,252          $44.19        $276,276
PFS Supplemental........................             253               1             253               1             253           44.19          11,180
PDO/FR CARA Supplemental................             109               2             218               1             218           44.19           9,633
SPF Rx Supplemental.....................              26               4             104               1             104           44.19           4,596
STOP Act Supplemental...................             133               1             133               1             133           44.19           5,877
                                         ---------------------------------------------------------------------------------------------------------------
    FY2021-FY2024 Total.................             521  ..............  ..............  ..............           6,960  ..............         307,562
--------------------------------------------------------------------------------------------------------------------------------------------------------

    Written comments and recommendations for the proposed information 
collection should be sent within 30 days of publication of this notice 
to www.reginfo.gov/public/do/PRAMain. Find this particular information 
collection by selecting ``Currently under 30-day Review--Open for 
Public Comments'' or by using the search function.

Carlos Graham,
Social Science Analyst.
[FR Doc. 2021-20608 Filed 9-22-21; 8:45 am]
BILLING CODE 4162-20-P